The main constituents, harmine and harmaline, have displayed therapeutic efficacy against Alzheimer’s disease (AD); however, the P. harmala potential on sensitizing central insulin to combat AD remains to be clarified. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.